Barow, Ewgenia
Pinnschmidt, Hans
Boutitie, Florent
Königsberg, Alina
Ebinger, Martin
Endres, Matthias
Fiebach, Jochen B.
Fiehler, Jens
Thijs, Vincent
Lemmens, Robin
Muir, Keith W.
Nighoghossian, Norbert
Pedraza, Salvador
Simonsen, Claus Z.
Gerloff, Christian
Thomalla, Götz
Cheng, Bastian
,
Article History
Received: 22 March 2020
Accepted: 19 May 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: Patients or their legal representatives provided written informed consent according to national and local regulations, with an exception from explicit informed consent in emergency circumstances in some countries. The trial was approved for each study site by the competent authorities and the corresponding ethics committee.
: Not applicable.
: EB, AK, MEb, MEn, JBF, JF, VT, RL, KWM, NN, SP, CZS, CG, GT and BC report grants from European Union 7th Framework Program during the conduct of the study. FB reports grants from University Medical Center Hamburg-Eppendorf during the conduct of the study. MEn reports grants from Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, Sanofi, Covidien, outside the submitted work. JBF reports consulting and advisory board fees from BioClinica, Cerevast, Artemida, Brainomix, Biogen, BMS, and EISAI, outside the submitted work. VT reports personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan, outside the submitted work. RL reports fees paid to VIB/KU Leuven from Bayer, Boehringer Ingelheim, Medtronic, Ischemiaview and Genentec, outside the submitted work. KWM reports personal fees and non-financial support from Boehringer Ingelheim, outside the submitted work. CZS reports grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. CG reports personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. Personal fees from Acandis, Boehringer Ingelheim, BMS/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation, outside the submitted work. All remaining authors declare that they have no competing interests.